Iptor appoints Richard Farnworth as Chief Revenue Officer
Appointment set to further drive new customer acquisition and growth of Iptor.com
Entries by Mike Kissel
National Swap Ideas Day – Remote Working Tips and Life Hacks
Today is National Swap Ideas Day. Observed annually on September 10th, this day encourages us to share creative and helpful ideas with someone and trade them for their thoughts in […]
Chargeback and Rebate Management for Pharma Distributors
The word “leakage is never used to describe something good. For any business, the problem of revenue leakage is doubly unpleasant, both for what it means to the top and […]
Suspicious Order Monitoring Challenges for Pharma Distributors
As a pharma distributor, compliance challenges are nothing new. In a high-stakes industry where your products affect the health and lives of millions of consumers, you are kept on strict […]
Iptor.com cloud platform heralds the future of ERP and supply chain software
User-experience, automation and self-service at forefront of conquering complex fulfilment challenges
Can Blockchain Solve Pharma Supply Chain Challenges?
If you haven’t heard the word “blockchain,” you will soon enough. It’s the technology behind Non-Fungible Tokens (NFTs), which have been making a lot of news this year. Cryptocurrencies like […]
Simplifying DSCSA compliance with a single, integrated business system
Regulatory compliance is a lot like a treasure map from an old pirate movie. You’ve got to follow the directions to the letter, a task made more difficult by the […]
Three IT considerations for long-term sustainability around DSCSA compliance
The Drug Supply Chain Security Act (DSCSA) isn’t exactly news to the pharmaceutical industry. But it still presents many challenges for distributors to overcome. The law was passed in 2013, […]
3 Ways an Outdated ERP System is Hurting Pharmaceutical Distributors
Technology is supposed to make life easier. Imagine owning a car that no longer drove as fast as it used to, and every few days it just stopped working until […]
